APA

Bombardo M., Saponara E., Malagola E., Chen R., Seleznik G. M., Haumaitre C., Quilichini E., Zabel A., Reding T., Graf R. & Sonda S. (20180530). Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia. : British journal of pharmacology.

Chicago

Bombardo Marta, Saponara Enrica, Malagola Ermanno, Chen Rong, Seleznik Gitta M, Haumaitre Cecile, Quilichini Evans, Zabel Anja, Reding Theresia, Graf Rolf and Sonda Sabrina. 20180530. Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia. : British journal of pharmacology.

Harvard

Bombardo M., Saponara E., Malagola E., Chen R., Seleznik G. M., Haumaitre C., Quilichini E., Zabel A., Reding T., Graf R. and Sonda S. (20180530). Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia. : British journal of pharmacology.

MLA

Bombardo Marta, Saponara Enrica, Malagola Ermanno, Chen Rong, Seleznik Gitta M, Haumaitre Cecile, Quilichini Evans, Zabel Anja, Reding Theresia, Graf Rolf and Sonda Sabrina. Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia. : British journal of pharmacology. 20180530.